Analyzing Cronos Group (CRON) & Mannatech (MTEX)

Cronos Group (NASDAQ:CRON) and Mannatech (NASDAQ:MTEX) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.


This table compares Cronos Group and Mannatech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cronos Group 30.64% 2.23% 2.05%
Mannatech -1.71% 5.66% 2.85%


Mannatech pays an annual dividend of $2.00 per share and has a dividend yield of 12.3%. Cronos Group does not pay a dividend.

Insider and Institutional Ownership

9.7% of Cronos Group shares are owned by institutional investors. Comparatively, 24.0% of Mannatech shares are owned by institutional investors. 24.7% of Mannatech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Cronos Group and Mannatech’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cronos Group $3.15 million 417.36 $1.92 million $0.01 742.00
Mannatech $176.70 million 0.22 -$1.78 million N/A N/A

Cronos Group has higher earnings, but lower revenue than Mannatech.

Analyst Ratings

This is a summary of recent recommendations and price targets for Cronos Group and Mannatech, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group 1 1 2 0 2.25
Mannatech 0 0 0 0 N/A

Cronos Group presently has a consensus target price of $4.50, suggesting a potential downside of 39.35%. Given Cronos Group’s higher probable upside, research analysts plainly believe Cronos Group is more favorable than Mannatech.

About Cronos Group

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in in Toronto, Canada.

About Mannatech

Mannatech, Incorporated provides wellness solutions. The company develops, markets, and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It markets its products through network marketing channels in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific. The company was founded in 1993 and is headquartered in Coppell, Texas.

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with's FREE daily email newsletter.

Leave a Reply